Article Text

Download PDFPDF
CASE REPORT
Unusual case of a rectal tumour
  1. Maryam Alfa-Wali1,
  2. Samantha Muktar2,
  3. Dimitrios Pissas3,
  4. Ceri Slater2
  1. 1Imperial College London, London, UK
  2. 2Epsom and Saint Helier University Hospitals NHS Trust, Carshalton, UK
  3. 3Epsom and Saint Helier University Hospitals NHS Trust, London, UK
  1. Correspondence to Dr Maryam Alfa-Wali, m.alfa{at}doctors.org.uk

Summary

A 48-year-old man presented as an emergency with a 3-week history of rectal bleeding. Examination of his rectum revealed a circumferential tumour, 2 cm from the anal verge. An MRI scan reported a locally infiltrative mid-lower rectal tumour staged as T3d/T4 N2 MX. A colonoscopy revealed appearances of severe proctitis and biopsies did not show any evidence of dysplasia or malignancy. The patient was discussed at the regional colorectal cancer multidisciplinary team meeting with a management plan for neoadjuvant chemoradiotherapy following repeat biopsies, which were again negative for malignancy. He tested positive for the HIV and was referred to genitourinary medicine. A positive Chlamydia trachomatis nucleic acid test from a rectal swab was serovar L2 consistent with a diagnosis of lymphogranuloma venereum. He was treated with doxycycline and subsequent MRI scans showed reduction in tumour size with eventual resolution. This case report highlights the importance of HIV testing in patients with newly diagnosed colorectal tumours.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors MAW and CS: reviewing literature, writing case report and reviewing of manuscript. SM: literature review. DP: review of manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.